
STD Testing Rates, Service Receipt Among HIV-Positive MSM Remain Low
The CDC recommends regular testing for bacterial sexually transmitted diseases (STDs) among all sexually active gay, bisexual, and other men who have sex with men (MSM). Chief among these STDs are gonorrhea, chlamydia, syphilis, and hepatitis C.
The CDC recommends regular testing for bacterial sexually transmitted diseases (STDs) among all sexually active gay, bisexual, and other men who have sex with men (MSM) because they have a
“Having an STD (like gonorrhea) makes it easier to get HIV or give it to others, so it’s important that you get tested to protect your health and the health of your partner,”
Despite these guidelines, there has been a constant uptick in STDs over the past decade, particularly among
The primary outcome of their study was to determine both deficiencies in bacterial STD testing and what risky behaviors result in these deficiencies among HIV-positive MSM—especially because having an STD increases the risk of transmitting HIV.
Data were gleaned from the
The patient population consisted of 1269 HIV-positive MSM who self-reported on the following risk behaviors as they pertained to transmission of gonorrhea, chlamydia, syphilis, and HCV:
- Sexual behaviors
- Drug and alcohol use before or during sex
- HIV or STD prevention services
Between June 2017 and May 2018,
Broken down by STD, however, the numbers were worse, except for syphilis:
- Gonorrhea: Overall: 49.7% Non—RWHAP-funded facilities: 37.2% RWHAP-funded facilities: 57.4%
- Chlamydia: Overall: 49.4% Non—RWHAP-funded facilities: 36.7% RWHAP-funded facilities: 57.2%
- HCV: Overall: 34.5% Non—RWHAP-funded facilities: 26.8% RWHAP-funded facilities: 39.2%
- Syphilis: Overall: 68.3% Non—RWHAP-funded facilities: 58.4% RWHAP-funded facilities: 74.5%
The results on patients’ risky behaviors were alarming, too. Close to 64.5% (95% CI, 60.3%-68.6%) had condomless anal sex in the past year; 46.9% (95% CI, 43.0%-50.8%) reported they drank alcohol before or during sex; 35.8% (95% CI, 32.2%-39.4%) used noninjection drugs before or during sex; and 3.7% (95% CI, 2.2%-5.2%) used injectable drugs before or during sex.
All sets of results leave much room for improvement, because they show that many of the survey respondents still “did not receive recommended prevention services and STD testing, particularly testing for extragenital gonorrhea and chlamydia, which is essential for reducing STDs in this population,” the authors noted. “Meeting public health goals for preventing STDs, and in turn ending the HIV epidemic, may require closer adherence to guidelines for delivering prevention services and STD testing to HIV-positive MSM.”
To help adhere to the guidelines, they reiterate the importance of evidence-based strategies that include nurse-led programs, self-swabbing for gonorrhea and chlamydia, and monitoring provider performance.
Reference
Weiser J, Tie Y, Beer L, Pearson WS, Shouse RL. Receipt of prevention services and testing for sexually transmitted diseases among HIV-positive men who have sex with men, United States [published online May 4, 2020]. Ann Intern Med. doi: 10.7326/M19-4051.
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.